Status:
COMPLETED
Effects of OM-174 in Adult Patients With Solid Tumors
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Solid Tumors
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Methods Patients received OM-174 twice weekly for a total of 5, 10 or 15 injections of either 600, 800 or 1000 µg/m². Pharmacokinetic analysis and cytokine dosages were performed. Natural Killer cells...
Eligibility Criteria
Inclusion
- Patient with a histologically proven solid tumor, refractory to conventional treatment or for which no such treatment existed.
- At least one month since the last chemotherapy
- Life expectancy above 3 months
- Written informed consent
- Age above 18
Exclusion
- Patient's refusal
- Infection
- Brain metastasis
- Autoimmune disease
- Regular use of steroids
- Patient included in another protocol
- Chemotherapy or radiotherapy less than 6 weeks ago
- Immunotherapy less than 8 weeks ago
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01800812
Start Date
March 1 2007
Last Update
February 28 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.